Skip to main content
Journal of the Advanced Practitioner in Oncology logoLink to Journal of the Advanced Practitioner in Oncology
editorial
. 2023 Sep 1;14(6):478–482. doi: 10.6004/jadpro.2023.14.6.2

Precautions for Patients Taking Tamoxifen or Aromatase Inhibitors

Mary Heery 1,
PMCID: PMC10558019  PMID: 37808073

graphic file with name jadpro-14-478-g001.jpg

Tamoxifen and aromatase inhibitors are widely prescribed therapies for the treatment of breast cancer. Tamoxifen is a selective estrogen receptor modulator that treats hormone-sensitive breast cancers. Research has demonstrated that tamoxifen therapy improves survival and reduces the risk of developing recurrent invasive breast cancer by up to 40%.

Aromatase inhibitors are the drug of choice for the treatment of estrogen receptor– or progesterone receptor–positive breast cancer in postmenopausal women. Research on aromatase inhibitors has demonstrated improved survival in postmenopausal women, postmenopausal women with metastasis, and premenopausal women under the age of 35 with ovarian ablation.

The benefits of these agents have been clearly shown through various clinical trials, yet adherence may be challenging for some patients due to issues of drug interactions, proper education, and adverse effects. Education to prevent and treat adverse effects is of the utmost importance to promote adherence and improve the effectiveness of these medications. Advanced practitioners are in a position to prescribe these therapies, review medication interactions, educate patients, impact patients' quality of life, improve patients' sense of control, and increase patients' partnerships with their oncology providers.

In 2018 and 2020, two articles on precautions for patients taking tamoxifen and precautions for patients taking aromatase inhibitors were published in the Journal of the Advanced Practitioner in Oncology (Heery et al., 2018, 2020). Since then, more information on drug interactions has come to light. This article contains updated patient teaching sheets to aid the advanced practitioner in providing education to patients on these medications (Tables 1 and 2). Permission to reprint and distribute these sheets is granted.

Table 1. Precautions for Patients Taking Tamoxifen.

Tamoxifen has been the most widely prescribed medication for breast cancer for over 25 years. Daily use of tamoxifen has been shown to improve survival and reduce the risk of developing recurrent invasive breast cancer by up to 40%.
Medications to Avoid or Use With Caution
Certain medications should be avoided or taken with caution while taking tamoxifen, as they may provide less protection against breast cancer:
  • Antidepressants such as bupropion (Aplenzin, Forfivo XL, Wellbutrin SR/XL, Zyban), duloxetine (Cymbalta, Drizalma Sprinkle, Irenka), fluoxetine (Prozac, Sarafem, Selfemra, Rapiflux), and paroxetine (Brisdelle, Paxil, Pexeva)

  • Cardiac medications such as amiodarone (Pacerone), dronedarone (Multaq), quinidine (Quinidex, Quinaglute), sotalol (Betapace, Sorine, Sotalol Hydrochloride AF, Sotylize), and ticlopidine (Ticlid)

  • HIV medications such as cobicistat (Tybost), ritonavir (Norvir), tipranavir (Aptivus), elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (Genvoya), and elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (Stribild)

  • Neuroleptics such as perphenazine (Trilafon), pimozide (Orap), and thioridazine (Mellaril)

  • Anti-infective agents such as hydroxychloroquine (Plaquenil), quinidine (Cardioquin), rifampin (Rifadin), and terbinafine (Lamisil)

  • Other medications like cinacalcet (Sensipar), conivaptan (Vaprisol), haloperidol (Haldol), and mirabegron (Myrbetriq)

Anticoagulants
  • Warfarin (Coumadin, Jantoven) should be closely monitored and discussed with your oncology provider.

Estrogen Products/Estradiol Derivatives
  • Discuss all estrogen products with your health-care provider.

Other Medications
  • Colchicine (Colcrys, Mitigare, Gloperba), dabigatran (Pradaxa), rifaximin (Xifaxan), and rivaroxaban (Xarelto) should be used with caution because of an increased risk of side effects from the medications.

Alcohol
  • Alcohol should be avoided or limited while taking tamoxifen, as alcohol consumption may decrease the efficacy of this medication.

Surgical Considerations
Before surgery, please discuss tamoxifen usage with your surgeon. Tamoxifen may need to be held for several days before and after surgery to prevent the risk of increased bleeding.
  • Notify your surgeon if you are taking garlic, ginger, ginkgo, glucosamine, green tea, guarana, and/or high doses of vitamin E and fish oil, as they may impact bleeding.

Supplements
Some herbs, supplements, and other products can impact the effectiveness of your cancer treatment. Talk with your provider or health-care team if you are taking any of these products. The products listed below may cause problems with breast cancer or breast cancer treatment when taken in concentrated doses such as supplement form. These products are not normally harmful if found in the food that you eat as part of your regular diet.
  • Aletris

  • Alfalfa

  • Anise/Star anise

  • Bitter melon

  • Black/Blue Cohosh

  • Chamomile

  • Chasteberry

  • Diindolylmethane (DIM)

  • Dong quai

  • Echinacea

  • Fennel

  • Flaxseed/hops

  • Ginseng

  • Guggul

  • High protein supplements

  • Isoflavones/Plant estrogens

  • Kudzu

  • Maca

  • Noni juice

  • Red clover

  • Red raspberry leaf

  • Scarlet pimpernel

  • Soy supplements

  • St. John's wort

  • Turmeric/Curcumin

  • Valerian

Note. Generic drug names and common brand names listed only. Always tell your provider or health-care team all the medications, herbs, supplements, vitamins, and minerals that you are taking. Reprint permission granted.

© 2023 Mary Heery, John Healey, Rachel Sieber, Emily McAllister, Ellen Konspore, Lisa Phuong, and George Zahrah.

Table 2. Precautions for Patients Taking Aromatase Inhibitors.

Aromatase inhibitors are the gold standard for postmenopausal women with breast cancer. Daily use of an aromatase inhibitor has been shown to improve survival and reduce the risk of developing recurrent invasive breast cancer by up to 40%.
Medications to Avoid or Use With Caution While Taking Anastrozole or Letrozole
Certain medications should be avoided or used with caution while taking anastrozole or letrozole.
  • Neuroleptics such as aripiprazole (Abilify) and pimozide (Orap)

  • Cardiac medications such as dofetilide (Tikosyn)

  • Pain medications such as hydrocodone (Vicodin) or methadone (Dolophine, Methadose)

Medications to Avoid or Use With Caution While Taking Exemestane
Certain medications should be avoided or used with caution while taking exemestane.
  • Diabetes medications such as saxagliptin (Onglyza)

  • Antidepressants such as St. John's wort

  • Anticonvulsants such as carbamazepine (Epitol, Equetro, Tegretol), oxcarbazepine (Trileptal), phenobarbital (Solfoton, Luminal), and phenytoin (Dilantin, Phenytek)

  • Pain medications such as hydrocodone (Vicodin) and methadone (Dolophine)

  • Anti-infective agents such as azithromycin (Zithromax), clarithromycin (Klaricid), efavirenz (Sustiva), nevirapine (Viramune), ritonavir (Norvir), cobicistat (Tybost), elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (Genvoya), elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (Stribild), rifampin (Rimactane), rifabutin (Mycobutin), voriconazole (Vfend), ketoconazole (Nizarol), and itraconazole (Sporanox)

  • Heart/blood pressure medications such as amiodarone (Pacerone), diltiazem (Adizem), and verapamil (Isoptin)

Other Precautions
  • Estrogen products/estradiol derivatives: Discuss all estrogen products with your health-care provider.

  • Alcohol should be avoided or limited while taking aromatase inhibitors, as alcohol consumption may decrease the efficacy of this medication.

  • Avoid grapefruit juice and particularly the specific class of Seville or “bitter” oranges, as they can interfere with the efficacy of exemestane. Normal store-bought orange juice is ok.

Supplements
Some herbs, supplements, and other products can impact the effectiveness of your cancer treatment. Talk with your provider or health-care team if you are taking any of these products. The products listed below may cause problems with breast cancer or breast cancer treatment when taken in concentrated doses such as supplement form. These products are not normally harmful if they are found in the food that you eat as part of your regular diet.
  • Aletris

  • Alfalfa

  • Androstenediol

  • Androstenedione

  • Anise/Star anise

  • Black/Blue cohosh

  • Chasteberry

  • Chamomile

  • Dandelion

  • Diindolylmethane (DIM)

  • Dong quai

  • Echinacea

  • Fennel

  • Flaxseed

  • Ginseng

  • Grapefruit juice

  • Guggul

  • Hu zhang

  • Isoflavones/Plant estrogens

  • Kudzu

  • Maca

  • Milk thistle

  • Noni juice

  • Panax ginseng

  • Red clover

  • Red raspberry leaf

  • Resveratrol

  • Saw palmetto

  • Scarlet pimpernel

  • St. John's wort

  • Turmeric/Curcumin

  • Valerian

  • (Whey) High protein supplements

Note. Generic drug names and common brand names listed only. Always tell your provider or health-care team all the medications, herbs, supplements, vitamins, minerals that you are taking. Please consult your health-care provider for more information. Reprint permission granted.

© 2023 Mary Heery, John Healey, Rachel Sieber, Emily McAllister, Ellen Konspore, Lisa Phuong, and George Zahrah.

References

  1. Heery, M., Corbett, P., & Zelkowitz, R. (2018). Precautions for patients taking tamoxifen. Journal of the Advanced Practitioner in Oncology, 9(1), 78–83. 10.6004/jadpro.2018.9.1.6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Heery, M., Farley, S., Sparkman, R., Healy, J., Eighmy, W., Zahrah, G., & Zelkowitz, R. (2020). Precautions for patients taking aromatase inhibitors. Journal of the Advanced Practitioner in Oncology, 11(2), 184–189. 10.6004/jadpro.2020.11.2.6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Advanced Practitioner in Oncology are provided here courtesy of BroadcastMed LLC

RESOURCES